Viewing StudyNCT02410733



Ignite Creation Date: 2024-05-06 @ 3:57 AM
Last Modification Date: 2024-10-26 @ 11:41 AM
Study NCT ID: NCT02410733
Status: COMPLETED
Last Update Posted: 2023-07-19
First Post: 2015-03-24

Brief Title: Evaluation of the Safety and Tolerability of iv Administration of a Cancer Vaccine in Patients With Advanced Melanoma
Sponsor: BioNTech SE
Organization: BioNTech SE

Conditions & Keywords Data

Conditions:
Name
Melanoma
Keywords:
Name View
BNT111 View
melanoma View
Lipo-MERIT View
cancer vaccine View
RB_0003-01 View
BioNTech View
BioNTech SE View
BioNTech RNA View
RNA View
RNA vaccine View